| 07/05/2008 |
03:00 AM |
|
New Antibiotic Beats Superbugs At Their Own Game |
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them.
|
| 07/03/2008 |
05:00 AM |
|
Risk Of Infection And Death Greater In Carriers Of MRSA |
Patients harboring methicillin-resistant Staphylococcus aureus (MRSA) for long periods of time continue to be at increased risk of MRSA infection and death, according to a new study in the July 15 issue of Clinical Infectious Diseases, currently available online. MRSA is an antibiotic-resistant bacterium that can cause a variety of serious infections. The bacterium most commonly colonizes the nostrils, although it can be found in other body sites.
|
| 07/03/2008 |
01:00 AM |
|
SinoFresh Announces "Next Step" In Program To Attack "Super-Bug" MRSA |
SinoFresh HealthCare, Inc. (OTCBB: SFSH), the makers of SinoFresh Nasal Spray, announced the next step in a research and development program expected to lead to a nasal spray product for attacking MRSA -- the so-called "super bug" -- reservoirs in the nasal passage. These nasal reservoirs are believed by public health experts to be a significant source of MRSA infections.
|
| 07/02/2008 |
03:00 AM |
|
British Society For Antimicrobial Chemotherapy Launch The First Evidence-based UK Guidelines To Tackle Hospital-acquired Pneumonia (HAP) |
The British Society for Antimicrobial Chemotherapy (BSAC) published the first evidence-based UK guidelines to address the management of hospital-acquired pneumonia (HAP) which is the most common hospital acquired infection in intubated1 patients increasing mortality by up to 75%2.
|
| 07/02/2008 |
01:00 AM |
|
Taking Action Against Hospital Acquired Infection |
Patients enter hospitals every day for a variety of reasons but usually without the thought of developing a new health problem. Yet every year thousands of hospitalized Americans acquire infections during hospital stays, causing risk of complications, prolonged stays and an increased burden on the health-care system. With fast track funding by the U.S.
|
| 07/01/2008 |
05:00 AM |
|
Wound-Cleaning Laser Proves That Bacterial Resistance Is Futile |
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
|
| 07/01/2008 |
05:00 AM |
|
MRSA Linked To Rising Number Of Severe Bone Infections, Health Complications In Children |
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) as a major pathogen has led to more complications and longer hospital stays for children with acute bone infections, UT Southwestern Medical Center researchers report. Acute osteomyelitis, a bone infection that predominantly occurs in children, is usually caused by the staph bacteria. Treatment has traditionally been straightforward because most S. aureus bacteria can be killed with existing antibiotics.
|
| 06/26/2008 |
03:00 AM |
|
Number Of Patients Treated With An Antibiotic For MRSA Within U.S. Acute Care Hospitals Increased 8 Percent From 2006 To 2007 |
Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the number of patients treated with an antibiotic associated with a positive culture for MRSA within U.S. acute care hospitals has increased from 2006 to 2007 by 8 percent.
|
| 06/25/2008 |
01:00 PM |
|
Immediate Action Taken On Healthcare Commission Improvement Notice - Hospital Acquired Infections Continue To Fall At Ashford & St. Peter's Hospitals |
"The Healthcare Commission have an important role to play in ensuring high standards and we welcomed and cooperated fully with their inspection of both Ashford and St. Peter's Hospitals on 5th and 6th June," says Ashford and St. Peter's Chief Executive, Paul Bentley.
|
| 06/25/2008 |
03:00 AM |
|
Athletes Susceptible To Antibiotic-resistant Staph Infections |
Methicillin-resistant Staphylococcus aureus, commonly referred to as MRSA, is a type of staph that causes infections resistant to a class of common antibiotics that includes methicillin, penicillin, amoxicillin and oxacillin. While MRSA infections were traditionally associated with extended hospital stays, they are now becoming more common in everyday life.
|
